NEO
Neogenomics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.88
-0.10 ▼ -1.25%
🌙 3월 13일 7:55 PM ET (한국 3/14 08:55)
$7.95
+0.07 ▲ +0.89%
| Index | RUT | P/E | - | EPS (ttm) | -0.84 | Insider Own | 1.46% | Shs Outstand | 0.13B | Perf Week | -12.05% |
| Market Cap | 1.02B | Forward P/E | 25.08 | EPS next Y | 82.8% | Insider Trans | -2.22% | Shs Float | 0.13B | Perf Month | -31.18% |
| Enterprise Value | 1.27B | PEG | 0.46 | EPS next Q | 0.01 | Inst Own | 101.26% | Short Float | 6.61% | Perf Quarter | -34.33% |
| Income | -0.11B | P/S | 1.41 | EPS this Y | 43.23% | Inst Trans | 6.75% | Short Ratio | 4.42 | Perf Half Y | -5.52% |
| Sales | 0.73B | P/B | 1.22 | EPS next 5Y | 54.64% | ROA | -7.21% | Short Interest | 8.46M | Perf YTD | -32.99% |
| Book/sh | 6.49 | P/C | 6.41 | EPS past 3/5Y | 10.12% - | ROE | -12.42% | 52W High | -42.65% ($13.74) | Perf Year | -17.23% |
| Cash/sh | 1.23 | P/FCF | - | Sales past 3/5Y | 12.58% 10.35% | ROIC | -8.7% | 52W Low | 66.95% ($4.72) | Perf 3Y | -55.33% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -35.69% | Gross Margin | 40.82% | Volatility(W/M) | 5.51% 6.48% | Perf 5Y | -83.99% |
| Dividend TTM | - | EV/Sales | 1.75 | Sales Y/Y TTM | 10.11% | Oper. Margin | -9.55% | ATR (14) | 0.54 | Perf 10Y | 12.25% |
| Dividend Ex-Date | - | Quick Ratio | 3.94 | EPS Q/Q | 36.27% | Profit Margin | -14.85% | RSI (14) | 18.78 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.26 | Sales Q/Q | 10.56% | SMA20 | -17.29% ($9.53) | Beta | 1.68 | Target Price | $13.94 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 2000000 | SMA50 | -29.6% ($11.19) | Rel Volume | 0.75 | Prev Close | $7.98 |
| Employees | 2500 | LT Debt/Eq | 0.48 | EPS/Sales Surpr. | 56.66% 0.89% | SMA200 | -15.01% ($9.27) | Avg Volume(3M) | 1.91M | Price | $7.88 |
| IPO | 1999/11/10 | Option/Short | Yes/Yes | Trades | 13056 | Volume | 1,440,568 | Change | -1.25% |
뉴스 로딩 중...